chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Diarrhoea, Diverticulum intestinal, Dyspnoea
Clinical narrative: This is a 72-year-old female past medical history of asthma, COPD, GERD, hypertension, CKD stage III, non-insulin-dependent diabetes, chronic anemia, anxiety/depression, migraines, history of pneumonia, prior history of COVID-19 infection in 2020, who presents to the emergency department with progressive shortness of breath for the past 3 to 5 days.  Patient stated she has been feeling generalized malaise, weak, fever at home, intermittent diarrhea, denies any chest pain, nausea, vomiting.  She did have nonbloody diarrhea 2-3 episodes, denies abdominal pain.  Denies any home oxygen use, has been previously COVID-19 vaccinated.   Upon arrival to the ED patient was tachypneic, tachycardic, low-grade fever 100.1, oxygen saturation in the 70s.  VBG with respiratory alkalosis, blood glucose 218, BUN/creatinine 39/1.34, troponin 17, repeat 20, CRP 2018, lactic acid 2.8, WBC 13.1, H/H90.8/31, tested positive for COVID-19.  CTA chest showed no PE, did show left greater than right basal consolidation, consistent with multifocal infection, colonic diverticulosis, patient received vancomycin, Zosyn, Decadron, IV fluids in the ED.  She is otherwise ill-appearing, alert and oriented x4, CODE STATUS discussed wishes to be DNR CCA DNI.   Clinical Summary Admitted with acute hypoxic respiratory failure secondary to COVID-19 and suspected secondary bacterial pneumonia, she was initiated on dexamethasone, remdesivir, broad-spectrum antibiotics.  She requires 4 L nasal cannula at night.  She was able to be weaned to her home oxygen requirements, able to ambulate on her own.  She was discharged with complete 10-day course of dexamethasone and coverage for community-acquired pneumonia.  There was some suspicion of aspiration on her final but unable to determine if she had aspiration event or if this is secondary to superimposed bacterial pneumonia.    Discharge diagnosis Acute on chronic hypoxic Respiratory Failure  secondary bacterial pneumonia, unable to determine if aspiration pneumonia Sepsis due to COVID-19 Acute COPD Exacerbation COVID-19
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: General physical condition abnormal, Haematocrit decreased, Haemoglobin increased, Lung consolidation, Malaise
Clinical narrative: This is a 72-year-old female past medical history of asthma, COPD, GERD, hypertension, CKD stage III, non-insulin-dependent diabetes, chronic anemia, anxiety/depression, migraines, history of pneumonia, prior history of COVID-19 infection in 2020, who presents to the emergency department with progressive shortness of breath for the past 3 to 5 days.  Patient stated she has been feeling generalized malaise, weak, fever at home, intermittent diarrhea, denies any chest pain, nausea, vomiting.  She did have nonbloody diarrhea 2-3 episodes, denies abdominal pain.  Denies any home oxygen use, has been previously COVID-19 vaccinated.   Upon arrival to the ED patient was tachypneic, tachycardic, low-grade fever 100.1, oxygen saturation in the 70s.  VBG with respiratory alkalosis, blood glucose 218, BUN/creatinine 39/1.34, troponin 17, repeat 20, CRP 2018, lactic acid 2.8, WBC 13.1, H/H90.8/31, tested positive for COVID-19.  CTA chest showed no PE, did show left greater than right basal consolidation, consistent with multifocal infection, colonic diverticulosis, patient received vancomycin, Zosyn, Decadron, IV fluids in the ED.  She is otherwise ill-appearing, alert and oriented x4, CODE STATUS discussed wishes to be DNR CCA DNI.   Clinical Summary Admitted with acute hypoxic respiratory failure secondary to COVID-19 and suspected secondary bacterial pneumonia, she was initiated on dexamethasone, remdesivir, broad-spectrum antibiotics.  She requires 4 L nasal cannula at night.  She was able to be weaned to her home oxygen requirements, able to ambulate on her own.  She was discharged with complete 10-day course of dexamethasone and coverage for community-acquired pneumonia.  There was some suspicion of aspiration on her final but unable to determine if she had aspiration event or if this is secondary to superimposed bacterial pneumonia.    Discharge diagnosis Acute on chronic hypoxic Respiratory Failure  secondary bacterial pneumonia, unable to determine if aspiration pneumonia Sepsis due to COVID-19 Acute COPD Exacerbation COVID-19
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia, Pneumonia bacterial, Pyrexia, Respiratory alkalosis, Respiratory failure
Clinical narrative: This is a 72-year-old female past medical history of asthma, COPD, GERD, hypertension, CKD stage III, non-insulin-dependent diabetes, chronic anemia, anxiety/depression, migraines, history of pneumonia, prior history of COVID-19 infection in 2020, who presents to the emergency department with progressive shortness of breath for the past 3 to 5 days.  Patient stated she has been feeling generalized malaise, weak, fever at home, intermittent diarrhea, denies any chest pain, nausea, vomiting.  She did have nonbloody diarrhea 2-3 episodes, denies abdominal pain.  Denies any home oxygen use, has been previously COVID-19 vaccinated.   Upon arrival to the ED patient was tachypneic, tachycardic, low-grade fever 100.1, oxygen saturation in the 70s.  VBG with respiratory alkalosis, blood glucose 218, BUN/creatinine 39/1.34, troponin 17, repeat 20, CRP 2018, lactic acid 2.8, WBC 13.1, H/H90.8/31, tested positive for COVID-19.  CTA chest showed no PE, did show left greater than right basal consolidation, consistent with multifocal infection, colonic diverticulosis, patient received vancomycin, Zosyn, Decadron, IV fluids in the ED.  She is otherwise ill-appearing, alert and oriented x4, CODE STATUS discussed wishes to be DNR CCA DNI.   Clinical Summary Admitted with acute hypoxic respiratory failure secondary to COVID-19 and suspected secondary bacterial pneumonia, she was initiated on dexamethasone, remdesivir, broad-spectrum antibiotics.  She requires 4 L nasal cannula at night.  She was able to be weaned to her home oxygen requirements, able to ambulate on her own.  She was discharged with complete 10-day course of dexamethasone and coverage for community-acquired pneumonia.  There was some suspicion of aspiration on her final but unable to determine if she had aspiration event or if this is secondary to superimposed bacterial pneumonia.    Discharge diagnosis Acute on chronic hypoxic Respiratory Failure  secondary bacterial pneumonia, unable to determine if aspiration pneumonia Sepsis due to COVID-19 Acute COPD Exacerbation COVID-19
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Superinfection, Tachycardia, Tachypnoea
Clinical narrative: This is a 72-year-old female past medical history of asthma, COPD, GERD, hypertension, CKD stage III, non-insulin-dependent diabetes, chronic anemia, anxiety/depression, migraines, history of pneumonia, prior history of COVID-19 infection in 2020, who presents to the emergency department with progressive shortness of breath for the past 3 to 5 days.  Patient stated she has been feeling generalized malaise, weak, fever at home, intermittent diarrhea, denies any chest pain, nausea, vomiting.  She did have nonbloody diarrhea 2-3 episodes, denies abdominal pain.  Denies any home oxygen use, has been previously COVID-19 vaccinated.   Upon arrival to the ED patient was tachypneic, tachycardic, low-grade fever 100.1, oxygen saturation in the 70s.  VBG with respiratory alkalosis, blood glucose 218, BUN/creatinine 39/1.34, troponin 17, repeat 20, CRP 2018, lactic acid 2.8, WBC 13.1, H/H90.8/31, tested positive for COVID-19.  CTA chest showed no PE, did show left greater than right basal consolidation, consistent with multifocal infection, colonic diverticulosis, patient received vancomycin, Zosyn, Decadron, IV fluids in the ED.  She is otherwise ill-appearing, alert and oriented x4, CODE STATUS discussed wishes to be DNR CCA DNI.   Clinical Summary Admitted with acute hypoxic respiratory failure secondary to COVID-19 and suspected secondary bacterial pneumonia, she was initiated on dexamethasone, remdesivir, broad-spectrum antibiotics.  She requires 4 L nasal cannula at night.  She was able to be weaned to her home oxygen requirements, able to ambulate on her own.  She was discharged with complete 10-day course of dexamethasone and coverage for community-acquired pneumonia.  There was some suspicion of aspiration on her final but unable to determine if she had aspiration event or if this is secondary to superimposed bacterial pneumonia.    Discharge diagnosis Acute on chronic hypoxic Respiratory Failure  secondary bacterial pneumonia, unable to determine if aspiration pneumonia Sepsis due to COVID-19 Acute COPD Exacerbation COVID-19
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin increased, White blood cell count increased
Clinical narrative: This is a 72-year-old female past medical history of asthma, COPD, GERD, hypertension, CKD stage III, non-insulin-dependent diabetes, chronic anemia, anxiety/depression, migraines, history of pneumonia, prior history of COVID-19 infection in 2020, who presents to the emergency department with progressive shortness of breath for the past 3 to 5 days.  Patient stated she has been feeling generalized malaise, weak, fever at home, intermittent diarrhea, denies any chest pain, nausea, vomiting.  She did have nonbloody diarrhea 2-3 episodes, denies abdominal pain.  Denies any home oxygen use, has been previously COVID-19 vaccinated.   Upon arrival to the ED patient was tachypneic, tachycardic, low-grade fever 100.1, oxygen saturation in the 70s.  VBG with respiratory alkalosis, blood glucose 218, BUN/creatinine 39/1.34, troponin 17, repeat 20, CRP 2018, lactic acid 2.8, WBC 13.1, H/H90.8/31, tested positive for COVID-19.  CTA chest showed no PE, did show left greater than right basal consolidation, consistent with multifocal infection, colonic diverticulosis, patient received vancomycin, Zosyn, Decadron, IV fluids in the ED.  She is otherwise ill-appearing, alert and oriented x4, CODE STATUS discussed wishes to be DNR CCA DNI.   Clinical Summary Admitted with acute hypoxic respiratory failure secondary to COVID-19 and suspected secondary bacterial pneumonia, she was initiated on dexamethasone, remdesivir, broad-spectrum antibiotics.  She requires 4 L nasal cannula at night.  She was able to be weaned to her home oxygen requirements, able to ambulate on her own.  She was discharged with complete 10-day course of dexamethasone and coverage for community-acquired pneumonia.  There was some suspicion of aspiration on her final but unable to determine if she had aspiration event or if this is secondary to superimposed bacterial pneumonia.    Discharge diagnosis Acute on chronic hypoxic Respiratory Failure  secondary bacterial pneumonia, unable to determine if aspiration pneumonia Sepsis due to COVID-19 Acute COPD Exacerbation COVID-19
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: The patient came in for an RSV vaccination. The patient handed their COVID19 CDC card to a technician who then grabbed a COVID (Comirnaty) shot out of the refrigerator upon seeing the card. He gave this to the immunizing technician who did not verify with the patient what shot she was here for and gave her the COVID shot and not the RSV vaccine. The patient last received a COVID shot 11/11/2023.
Age: 55.0
Sex: M
Vaccine: IPV, TYP, YF
Symptoms: Burning sensation, Chills, Cough, Decreased appetite, Erythema
Clinical narrative: Patient call in-this RN did not administer vaccines but spoke with patient on the phone. Please note the patient reports they have not yet taken the Typhoid vaccine. Patient reports tingling/burning of hands along with some redness that has improved since starting last week. Also reports muscle weakness in legs. Flu=-like symptoms (fever , chills, headache) and coughing as well as tearing of his eyes and decreased appetite.  Advised patient to seek medical care now for symptoms of tingling and muscle weakness.
Age: 55.0
Sex: M
Vaccine: IPV, TYP, YF
Symptoms: Headache, Influenza like illness, Lacrimation increased, Muscular weakness, Paraesthesia
Clinical narrative: Patient call in-this RN did not administer vaccines but spoke with patient on the phone. Please note the patient reports they have not yet taken the Typhoid vaccine. Patient reports tingling/burning of hands along with some redness that has improved since starting last week. Also reports muscle weakness in legs. Flu=-like symptoms (fever , chills, headache) and coughing as well as tearing of his eyes and decreased appetite.  Advised patient to seek medical care now for symptoms of tingling and muscle weakness.
Age: 55.0
Sex: M
Vaccine: IPV, TYP, YF
Symptoms: Pyrexia
Clinical narrative: Patient call in-this RN did not administer vaccines but spoke with patient on the phone. Please note the patient reports they have not yet taken the Typhoid vaccine. Patient reports tingling/burning of hands along with some redness that has improved since starting last week. Also reports muscle weakness in legs. Flu=-like symptoms (fever , chills, headache) and coughing as well as tearing of his eyes and decreased appetite.  Advised patient to seek medical care now for symptoms of tingling and muscle weakness.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Accelerated hypertension, Chest pain, Hyperglycaemia, Hypomagnesaemia, Hyponatraemia
Clinical narrative: Hospitalization for chest pain, accelerated hypertension, hyperglycemia, hypomagnesemia, hyponatremia on dates 12/17/2023- 12/18/2023. Treated with  vitamin C 500 mg PO daily, zinc 50 mg PO daily.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Atypical pneumonia, COVID-19, COVID-19 pneumonia
Clinical narrative: Patient is a 61 y.o. female with a history of OSA, HTN, Paraneoplastic Syndrome (GAD 65) with COVID 9/4/23 who presented to ED 10/3/23 with persistent fevers, dyspnea found to be septic with hypoxemia. Transferred to Facility for further care. Admitted for acute hypoxic respiratory failure is secondary to COVID-19 reinfection.    1. Acute hypoxic respiratory failure: Required nasal oxymizer, on oxygen through nasal cannula. CTPA 10/5/23 with multifocal opacities consistent with atypical PNA. COVID-19 swab 10/14/23 positive. Sputum culture negative.  Chest x-ray on 10/17/23 showed extensive bilateral mixed interstitial and airspace disease compatible with pneumonia . Wean as tolerated to keep sat>90%. On 3 L oxygen on 10/24/23.  2. Recurrent COVID-19 pneumonia, acute COVID: Initially diagnosed 9/4/23, s/p paxlovid with symptom resolution and suspect re-activation given immunodeficient state. Respiratory PCR 10/5/23 negative, COVID PCR 10/14/23 positive. Completed course of decadron on 10/13/23 per pulmonology recs. Started Remdesivir x5-d course (end 10/20 ) per ID recs. Finished 5 day course on 10/20/23.  ID followed.  No need for IVIG as an outpatient. Off isolation on 10/24/23.  3. Concern for CHF: Patient chest x-ray concerning for pneumonia versus pulmonary edema with cardiomegaly.  Lasix .  Echo on 10/18/2023 showed EF of 67% with borderline left ventricular hypertrophy.  No need for further cardiac work-up. S/p IV lasix. No further diuresis indicated.  4. Autoimmune GAD antibody syndrome: Follows with Dr., neurology. On rituximab q6months.  Consulted ID per patient request to discuss long-term goals for ongoing recurrent covid due to immunu- suppression status. 5. Chronic anemia: Baseline 11-12. Stable 6. OSA: Recent noncompliance due to tear in home mask. CPAP at bedtime
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Device breakage, Dyspnoea, Echocardiogram abnormal, Ejection fraction normal
Clinical narrative: Patient is a 61 y.o. female with a history of OSA, HTN, Paraneoplastic Syndrome (GAD 65) with COVID 9/4/23 who presented to ED 10/3/23 with persistent fevers, dyspnea found to be septic with hypoxemia. Transferred to Facility for further care. Admitted for acute hypoxic respiratory failure is secondary to COVID-19 reinfection.    1. Acute hypoxic respiratory failure: Required nasal oxymizer, on oxygen through nasal cannula. CTPA 10/5/23 with multifocal opacities consistent with atypical PNA. COVID-19 swab 10/14/23 positive. Sputum culture negative.  Chest x-ray on 10/17/23 showed extensive bilateral mixed interstitial and airspace disease compatible with pneumonia . Wean as tolerated to keep sat>90%. On 3 L oxygen on 10/24/23.  2. Recurrent COVID-19 pneumonia, acute COVID: Initially diagnosed 9/4/23, s/p paxlovid with symptom resolution and suspect re-activation given immunodeficient state. Respiratory PCR 10/5/23 negative, COVID PCR 10/14/23 positive. Completed course of decadron on 10/13/23 per pulmonology recs. Started Remdesivir x5-d course (end 10/20 ) per ID recs. Finished 5 day course on 10/20/23.  ID followed.  No need for IVIG as an outpatient. Off isolation on 10/24/23.  3. Concern for CHF: Patient chest x-ray concerning for pneumonia versus pulmonary edema with cardiomegaly.  Lasix .  Echo on 10/18/2023 showed EF of 67% with borderline left ventricular hypertrophy.  No need for further cardiac work-up. S/p IV lasix. No further diuresis indicated.  4. Autoimmune GAD antibody syndrome: Follows with Dr., neurology. On rituximab q6months.  Consulted ID per patient request to discuss long-term goals for ongoing recurrent covid due to immunu- suppression status. 5. Chronic anemia: Baseline 11-12. Stable 6. OSA: Recent noncompliance due to tear in home mask. CPAP at bedtime
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Immunodeficiency, Infection reactivation, Interstitial lung disease, Lung disorder
Clinical narrative: Patient is a 61 y.o. female with a history of OSA, HTN, Paraneoplastic Syndrome (GAD 65) with COVID 9/4/23 who presented to ED 10/3/23 with persistent fevers, dyspnea found to be septic with hypoxemia. Transferred to Facility for further care. Admitted for acute hypoxic respiratory failure is secondary to COVID-19 reinfection.    1. Acute hypoxic respiratory failure: Required nasal oxymizer, on oxygen through nasal cannula. CTPA 10/5/23 with multifocal opacities consistent with atypical PNA. COVID-19 swab 10/14/23 positive. Sputum culture negative.  Chest x-ray on 10/17/23 showed extensive bilateral mixed interstitial and airspace disease compatible with pneumonia . Wean as tolerated to keep sat>90%. On 3 L oxygen on 10/24/23.  2. Recurrent COVID-19 pneumonia, acute COVID: Initially diagnosed 9/4/23, s/p paxlovid with symptom resolution and suspect re-activation given immunodeficient state. Respiratory PCR 10/5/23 negative, COVID PCR 10/14/23 positive. Completed course of decadron on 10/13/23 per pulmonology recs. Started Remdesivir x5-d course (end 10/20 ) per ID recs. Finished 5 day course on 10/20/23.  ID followed.  No need for IVIG as an outpatient. Off isolation on 10/24/23.  3. Concern for CHF: Patient chest x-ray concerning for pneumonia versus pulmonary edema with cardiomegaly.  Lasix .  Echo on 10/18/2023 showed EF of 67% with borderline left ventricular hypertrophy.  No need for further cardiac work-up. S/p IV lasix. No further diuresis indicated.  4. Autoimmune GAD antibody syndrome: Follows with Dr., neurology. On rituximab q6months.  Consulted ID per patient request to discuss long-term goals for ongoing recurrent covid due to immunu- suppression status. 5. Chronic anemia: Baseline 11-12. Stable 6. OSA: Recent noncompliance due to tear in home mask. CPAP at bedtime
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Pneumonia, Polymerase chain reaction negative, Positive airway pressure therapy, Pyrexia
Clinical narrative: Patient is a 61 y.o. female with a history of OSA, HTN, Paraneoplastic Syndrome (GAD 65) with COVID 9/4/23 who presented to ED 10/3/23 with persistent fevers, dyspnea found to be septic with hypoxemia. Transferred to Facility for further care. Admitted for acute hypoxic respiratory failure is secondary to COVID-19 reinfection.    1. Acute hypoxic respiratory failure: Required nasal oxymizer, on oxygen through nasal cannula. CTPA 10/5/23 with multifocal opacities consistent with atypical PNA. COVID-19 swab 10/14/23 positive. Sputum culture negative.  Chest x-ray on 10/17/23 showed extensive bilateral mixed interstitial and airspace disease compatible with pneumonia . Wean as tolerated to keep sat>90%. On 3 L oxygen on 10/24/23.  2. Recurrent COVID-19 pneumonia, acute COVID: Initially diagnosed 9/4/23, s/p paxlovid with symptom resolution and suspect re-activation given immunodeficient state. Respiratory PCR 10/5/23 negative, COVID PCR 10/14/23 positive. Completed course of decadron on 10/13/23 per pulmonology recs. Started Remdesivir x5-d course (end 10/20 ) per ID recs. Finished 5 day course on 10/20/23.  ID followed.  No need for IVIG as an outpatient. Off isolation on 10/24/23.  3. Concern for CHF: Patient chest x-ray concerning for pneumonia versus pulmonary edema with cardiomegaly.  Lasix .  Echo on 10/18/2023 showed EF of 67% with borderline left ventricular hypertrophy.  No need for further cardiac work-up. S/p IV lasix. No further diuresis indicated.  4. Autoimmune GAD antibody syndrome: Follows with Dr., neurology. On rituximab q6months.  Consulted ID per patient request to discuss long-term goals for ongoing recurrent covid due to immunu- suppression status. 5. Chronic anemia: Baseline 11-12. Stable 6. OSA: Recent noncompliance due to tear in home mask. CPAP at bedtime
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory pathogen panel, SARS-CoV-2 test positive, Sepsis, Sputum culture, Treatment noncompliance
Clinical narrative: Patient is a 61 y.o. female with a history of OSA, HTN, Paraneoplastic Syndrome (GAD 65) with COVID 9/4/23 who presented to ED 10/3/23 with persistent fevers, dyspnea found to be septic with hypoxemia. Transferred to Facility for further care. Admitted for acute hypoxic respiratory failure is secondary to COVID-19 reinfection.    1. Acute hypoxic respiratory failure: Required nasal oxymizer, on oxygen through nasal cannula. CTPA 10/5/23 with multifocal opacities consistent with atypical PNA. COVID-19 swab 10/14/23 positive. Sputum culture negative.  Chest x-ray on 10/17/23 showed extensive bilateral mixed interstitial and airspace disease compatible with pneumonia . Wean as tolerated to keep sat>90%. On 3 L oxygen on 10/24/23.  2. Recurrent COVID-19 pneumonia, acute COVID: Initially diagnosed 9/4/23, s/p paxlovid with symptom resolution and suspect re-activation given immunodeficient state. Respiratory PCR 10/5/23 negative, COVID PCR 10/14/23 positive. Completed course of decadron on 10/13/23 per pulmonology recs. Started Remdesivir x5-d course (end 10/20 ) per ID recs. Finished 5 day course on 10/20/23.  ID followed.  No need for IVIG as an outpatient. Off isolation on 10/24/23.  3. Concern for CHF: Patient chest x-ray concerning for pneumonia versus pulmonary edema with cardiomegaly.  Lasix .  Echo on 10/18/2023 showed EF of 67% with borderline left ventricular hypertrophy.  No need for further cardiac work-up. S/p IV lasix. No further diuresis indicated.  4. Autoimmune GAD antibody syndrome: Follows with Dr., neurology. On rituximab q6months.  Consulted ID per patient request to discuss long-term goals for ongoing recurrent covid due to immunu- suppression status. 5. Chronic anemia: Baseline 11-12. Stable 6. OSA: Recent noncompliance due to tear in home mask. CPAP at bedtime
Age: 11.0
Sex: F
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was given an vaccine that Exp date was 11/18/23 and given on 11/29/23 we notice after given the  vaccine was exp after it was administered . patient was monitored for about 30 mins  and was doing well to be Discharged at that time .
Age: 31.0
Sex: F
Vaccine: TDAP
Symptoms: Immediate post-injection reaction, Incorrect route of product administration, Injection site pain, Muscle disorder, Nervous system disorder
Clinical narrative: Unsure if this is the exact tdap I was given. The shot was administered too high and the nurse injected it into my rotator cuff. Within 1 minute of receiving the vaccine, I became faint and needed to lay down in the exam room. Later that day, the muscles of my rotator cuff were in pain and felt ?locked.? I have been seen twice by Dr since this event and have now seen an orthopedist. I am still in extreme pain and have been diagnosed with a rotator cuff injury from vaccine administration as well as nerve irritation.
Age: 31.0
Sex: F
Vaccine: TDAP
Symptoms: Product administered at inappropriate site, Rotator cuff syndrome, Shoulder injury related to vaccine administration, Syncope, Ultrasound joint
Clinical narrative: Unsure if this is the exact tdap I was given. The shot was administered too high and the nurse injected it into my rotator cuff. Within 1 minute of receiving the vaccine, I became faint and needed to lay down in the exam room. Later that day, the muscles of my rotator cuff were in pain and felt ?locked.? I have been seen twice by Dr since this event and have now seen an orthopedist. I am still in extreme pain and have been diagnosed with a rotator cuff injury from vaccine administration as well as nerve irritation.
Age: 31.0
Sex: F
Vaccine: TDAP
Symptoms: X-ray limb
Clinical narrative: Unsure if this is the exact tdap I was given. The shot was administered too high and the nurse injected it into my rotator cuff. Within 1 minute of receiving the vaccine, I became faint and needed to lay down in the exam room. Later that day, the muscles of my rotator cuff were in pain and felt ?locked.? I have been seen twice by Dr since this event and have now seen an orthopedist. I am still in extreme pain and have been diagnosed with a rotator cuff injury from vaccine administration as well as nerve irritation.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blood lactic acid normal, Blood potassium decreased, Bronchoalveolar lavage abnormal, Bronchoscopy abnormal, C-reactive protein increased
Clinical narrative: Patient is a 42 y.o. female with a history of Ehlers-Danlos, MS, epilepsy, migraines with recent admission at hospital (10/12?19/23) for persistent COVID and bacterial superinfection who presented to RMH 10/22/2023 with persistent fevers and new onset emesis.    1. Recurrent Fevers of unknown origin:presented with persistent fevers and SIRs since her COVID dx. Likely viral sepsis present on admit. Normal lactate. Procal  was elevated 1.61, ESR 85, CRP 118 on admit. S/p bronchoscopy on 10/18/2023 with diffuse lung disease noted, cultures NGTD and she had elevated lymphocyte count in the  BAL. Concern for residual COVID infection/inflammation secondary to infection given immunocompromised stated due to MS medication CT chest  10/22/23 progression of airspace infiltrates. Initially treated with Vanco and Zoysn, abx stopped per Pulmonology and ID. Pulm followed. ID followed, patient responding to steroids. Improved.  2. Refractory emesis: Component of posttussive emesis noted but patient reports aggravation of oral intake as well. CT a/p 10/22/23 no acute process. Diet advanced as tolerated. 3. Hypokalemia: K of 3.1 (replaced 10/24) 4. COVID-19: Original DOP 9/20/2023 with repeat positive on 10/12/2023.  Patient did test negative on 10/14 with repeat + on 10/18 and 10/22/2023.  Patient on RA, on steroid treatment. Started remdesivir 10/25, finish outpatient 10/29. 5. Diarrhea: Concern for C. difficile on prior admit with test negative on 10/16/2023.  Stool frequency improved.  Monitored. 6. MS: On Kesimpa q28. Due 10/12/2023 but held for infectious concerns per neuro.   7. Epilepsy: No recent seizures reported, last 7/2021.  Home medications ordered. 8. Migraines: Per history.  Follows with Dr (Neuro). Refractory with Ubrelvy requested but denied by insurance.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Clostridium test negative, Computerised tomogram abdomen normal, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: Patient is a 42 y.o. female with a history of Ehlers-Danlos, MS, epilepsy, migraines with recent admission at hospital (10/12?19/23) for persistent COVID and bacterial superinfection who presented to RMH 10/22/2023 with persistent fevers and new onset emesis.    1. Recurrent Fevers of unknown origin:presented with persistent fevers and SIRs since her COVID dx. Likely viral sepsis present on admit. Normal lactate. Procal  was elevated 1.61, ESR 85, CRP 118 on admit. S/p bronchoscopy on 10/18/2023 with diffuse lung disease noted, cultures NGTD and she had elevated lymphocyte count in the  BAL. Concern for residual COVID infection/inflammation secondary to infection given immunocompromised stated due to MS medication CT chest  10/22/23 progression of airspace infiltrates. Initially treated with Vanco and Zoysn, abx stopped per Pulmonology and ID. Pulm followed. ID followed, patient responding to steroids. Improved.  2. Refractory emesis: Component of posttussive emesis noted but patient reports aggravation of oral intake as well. CT a/p 10/22/23 no acute process. Diet advanced as tolerated. 3. Hypokalemia: K of 3.1 (replaced 10/24) 4. COVID-19: Original DOP 9/20/2023 with repeat positive on 10/12/2023.  Patient did test negative on 10/14 with repeat + on 10/18 and 10/22/2023.  Patient on RA, on steroid treatment. Started remdesivir 10/25, finish outpatient 10/29. 5. Diarrhea: Concern for C. difficile on prior admit with test negative on 10/16/2023.  Stool frequency improved.  Monitored. 6. MS: On Kesimpa q28. Due 10/12/2023 but held for infectious concerns per neuro.   7. Epilepsy: No recent seizures reported, last 7/2021.  Home medications ordered. 8. Migraines: Per history.  Follows with Dr (Neuro). Refractory with Ubrelvy requested but denied by insurance.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Culture negative, Diarrhoea, Frequent bowel movements, Hypokalaemia, Lung disorder
Clinical narrative: Patient is a 42 y.o. female with a history of Ehlers-Danlos, MS, epilepsy, migraines with recent admission at hospital (10/12?19/23) for persistent COVID and bacterial superinfection who presented to RMH 10/22/2023 with persistent fevers and new onset emesis.    1. Recurrent Fevers of unknown origin:presented with persistent fevers and SIRs since her COVID dx. Likely viral sepsis present on admit. Normal lactate. Procal  was elevated 1.61, ESR 85, CRP 118 on admit. S/p bronchoscopy on 10/18/2023 with diffuse lung disease noted, cultures NGTD and she had elevated lymphocyte count in the  BAL. Concern for residual COVID infection/inflammation secondary to infection given immunocompromised stated due to MS medication CT chest  10/22/23 progression of airspace infiltrates. Initially treated with Vanco and Zoysn, abx stopped per Pulmonology and ID. Pulm followed. ID followed, patient responding to steroids. Improved.  2. Refractory emesis: Component of posttussive emesis noted but patient reports aggravation of oral intake as well. CT a/p 10/22/23 no acute process. Diet advanced as tolerated. 3. Hypokalemia: K of 3.1 (replaced 10/24) 4. COVID-19: Original DOP 9/20/2023 with repeat positive on 10/12/2023.  Patient did test negative on 10/14 with repeat + on 10/18 and 10/22/2023.  Patient on RA, on steroid treatment. Started remdesivir 10/25, finish outpatient 10/29. 5. Diarrhea: Concern for C. difficile on prior admit with test negative on 10/16/2023.  Stool frequency improved.  Monitored. 6. MS: On Kesimpa q28. Due 10/12/2023 but held for infectious concerns per neuro.   7. Epilepsy: No recent seizures reported, last 7/2021.  Home medications ordered. 8. Migraines: Per history.  Follows with Dr (Neuro). Refractory with Ubrelvy requested but denied by insurance.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Lymphocyte count increased, Post-tussive vomiting, Procalcitonin, Pyrexia
Clinical narrative: Patient is a 42 y.o. female with a history of Ehlers-Danlos, MS, epilepsy, migraines with recent admission at hospital (10/12?19/23) for persistent COVID and bacterial superinfection who presented to RMH 10/22/2023 with persistent fevers and new onset emesis.    1. Recurrent Fevers of unknown origin:presented with persistent fevers and SIRs since her COVID dx. Likely viral sepsis present on admit. Normal lactate. Procal  was elevated 1.61, ESR 85, CRP 118 on admit. S/p bronchoscopy on 10/18/2023 with diffuse lung disease noted, cultures NGTD and she had elevated lymphocyte count in the  BAL. Concern for residual COVID infection/inflammation secondary to infection given immunocompromised stated due to MS medication CT chest  10/22/23 progression of airspace infiltrates. Initially treated with Vanco and Zoysn, abx stopped per Pulmonology and ID. Pulm followed. ID followed, patient responding to steroids. Improved.  2. Refractory emesis: Component of posttussive emesis noted but patient reports aggravation of oral intake as well. CT a/p 10/22/23 no acute process. Diet advanced as tolerated. 3. Hypokalemia: K of 3.1 (replaced 10/24) 4. COVID-19: Original DOP 9/20/2023 with repeat positive on 10/12/2023.  Patient did test negative on 10/14 with repeat + on 10/18 and 10/22/2023.  Patient on RA, on steroid treatment. Started remdesivir 10/25, finish outpatient 10/29. 5. Diarrhea: Concern for C. difficile on prior admit with test negative on 10/16/2023.  Stool frequency improved.  Monitored. 6. MS: On Kesimpa q28. Due 10/12/2023 but held for infectious concerns per neuro.   7. Epilepsy: No recent seizures reported, last 7/2021.  Home medications ordered. 8. Migraines: Per history.  Follows with Dr (Neuro). Refractory with Ubrelvy requested but denied by insurance.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, SARS-CoV-2 test positive, Seizure, Superinfection bacterial, Systemic inflammatory response syndrome
Clinical narrative: Patient is a 42 y.o. female with a history of Ehlers-Danlos, MS, epilepsy, migraines with recent admission at hospital (10/12?19/23) for persistent COVID and bacterial superinfection who presented to RMH 10/22/2023 with persistent fevers and new onset emesis.    1. Recurrent Fevers of unknown origin:presented with persistent fevers and SIRs since her COVID dx. Likely viral sepsis present on admit. Normal lactate. Procal  was elevated 1.61, ESR 85, CRP 118 on admit. S/p bronchoscopy on 10/18/2023 with diffuse lung disease noted, cultures NGTD and she had elevated lymphocyte count in the  BAL. Concern for residual COVID infection/inflammation secondary to infection given immunocompromised stated due to MS medication CT chest  10/22/23 progression of airspace infiltrates. Initially treated with Vanco and Zoysn, abx stopped per Pulmonology and ID. Pulm followed. ID followed, patient responding to steroids. Improved.  2. Refractory emesis: Component of posttussive emesis noted but patient reports aggravation of oral intake as well. CT a/p 10/22/23 no acute process. Diet advanced as tolerated. 3. Hypokalemia: K of 3.1 (replaced 10/24) 4. COVID-19: Original DOP 9/20/2023 with repeat positive on 10/12/2023.  Patient did test negative on 10/14 with repeat + on 10/18 and 10/22/2023.  Patient on RA, on steroid treatment. Started remdesivir 10/25, finish outpatient 10/29. 5. Diarrhea: Concern for C. difficile on prior admit with test negative on 10/16/2023.  Stool frequency improved.  Monitored. 6. MS: On Kesimpa q28. Due 10/12/2023 but held for infectious concerns per neuro.   7. Epilepsy: No recent seizures reported, last 7/2021.  Home medications ordered. 8. Migraines: Per history.  Follows with Dr (Neuro). Refractory with Ubrelvy requested but denied by insurance.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Viral sepsis, Vomiting
Clinical narrative: Patient is a 42 y.o. female with a history of Ehlers-Danlos, MS, epilepsy, migraines with recent admission at hospital (10/12?19/23) for persistent COVID and bacterial superinfection who presented to RMH 10/22/2023 with persistent fevers and new onset emesis.    1. Recurrent Fevers of unknown origin:presented with persistent fevers and SIRs since her COVID dx. Likely viral sepsis present on admit. Normal lactate. Procal  was elevated 1.61, ESR 85, CRP 118 on admit. S/p bronchoscopy on 10/18/2023 with diffuse lung disease noted, cultures NGTD and she had elevated lymphocyte count in the  BAL. Concern for residual COVID infection/inflammation secondary to infection given immunocompromised stated due to MS medication CT chest  10/22/23 progression of airspace infiltrates. Initially treated with Vanco and Zoysn, abx stopped per Pulmonology and ID. Pulm followed. ID followed, patient responding to steroids. Improved.  2. Refractory emesis: Component of posttussive emesis noted but patient reports aggravation of oral intake as well. CT a/p 10/22/23 no acute process. Diet advanced as tolerated. 3. Hypokalemia: K of 3.1 (replaced 10/24) 4. COVID-19: Original DOP 9/20/2023 with repeat positive on 10/12/2023.  Patient did test negative on 10/14 with repeat + on 10/18 and 10/22/2023.  Patient on RA, on steroid treatment. Started remdesivir 10/25, finish outpatient 10/29. 5. Diarrhea: Concern for C. difficile on prior admit with test negative on 10/16/2023.  Stool frequency improved.  Monitored. 6. MS: On Kesimpa q28. Due 10/12/2023 but held for infectious concerns per neuro.   7. Epilepsy: No recent seizures reported, last 7/2021.  Home medications ordered. 8. Migraines: Per history.  Follows with Dr (Neuro). Refractory with Ubrelvy requested but denied by insurance.
Age: 90.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Blood pressure decreased, COVID-19, Computerised tomogram abnormal, Fall
Clinical narrative: Patient is a 91 y.o. female patient of MD with history of dementia and depression history of hypothyroidism, history of hypertension and hyperlipidemia was treated for non-Hodgkin lymphoma and is known for chronic pain syndrome lumbar spine stenosis and degenerative joint disease resulting in a nursing home is here following multiple falls complicated by scalp hematoma and was found to have COVID-positive otherwise chest image was negative for infiltrates and CAT scan of the chest will did not show any PE despite reported degree of hypoxia has large hiatus hernia, and blood pressure was soft on arrival at 90s systolic     COVID-19 respiratory infection Acute respiratory failure with hypoxia - now on RA chest image showed no infiltrates CAT scan is no PE  S/p 4 days of decadrn and remdesvir   Lactic acidosis POA - resolved S/p fluids Secondry to covid   Recurrent falls And reported head trauma complicated by scalp hematoma otherwise CAT scan of the brain showed no acute abnormalities and cervical spine no fractures PT OT evaluation -discharge to facility   hypothyroidism On thyroid replacement therapy   Alzhimers Dementia Confusion Appears to be at baseline Is maintained on Aricept
Age: 90.0
Sex: F
Vaccine: COVID19-2
Symptoms: Head injury, Hiatus hernia, Hypoxia, Lactic acidosis, Pulmonary imaging procedure normal
Clinical narrative: Patient is a 91 y.o. female patient of MD with history of dementia and depression history of hypothyroidism, history of hypertension and hyperlipidemia was treated for non-Hodgkin lymphoma and is known for chronic pain syndrome lumbar spine stenosis and degenerative joint disease resulting in a nursing home is here following multiple falls complicated by scalp hematoma and was found to have COVID-positive otherwise chest image was negative for infiltrates and CAT scan of the chest will did not show any PE despite reported degree of hypoxia has large hiatus hernia, and blood pressure was soft on arrival at 90s systolic     COVID-19 respiratory infection Acute respiratory failure with hypoxia - now on RA chest image showed no infiltrates CAT scan is no PE  S/p 4 days of decadrn and remdesvir   Lactic acidosis POA - resolved S/p fluids Secondry to covid   Recurrent falls And reported head trauma complicated by scalp hematoma otherwise CAT scan of the brain showed no acute abnormalities and cervical spine no fractures PT OT evaluation -discharge to facility   hypothyroidism On thyroid replacement therapy   Alzhimers Dementia Confusion Appears to be at baseline Is maintained on Aricept
Age: 90.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Scalp haematoma
Clinical narrative: Patient is a 91 y.o. female patient of MD with history of dementia and depression history of hypothyroidism, history of hypertension and hyperlipidemia was treated for non-Hodgkin lymphoma and is known for chronic pain syndrome lumbar spine stenosis and degenerative joint disease resulting in a nursing home is here following multiple falls complicated by scalp hematoma and was found to have COVID-positive otherwise chest image was negative for infiltrates and CAT scan of the chest will did not show any PE despite reported degree of hypoxia has large hiatus hernia, and blood pressure was soft on arrival at 90s systolic     COVID-19 respiratory infection Acute respiratory failure with hypoxia - now on RA chest image showed no infiltrates CAT scan is no PE  S/p 4 days of decadrn and remdesvir   Lactic acidosis POA - resolved S/p fluids Secondry to covid   Recurrent falls And reported head trauma complicated by scalp hematoma otherwise CAT scan of the brain showed no acute abnormalities and cervical spine no fractures PT OT evaluation -discharge to facility   hypothyroidism On thyroid replacement therapy   Alzhimers Dementia Confusion Appears to be at baseline Is maintained on Aricept
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Asthenia, COVID-19, Chest X-ray abnormal, Chills
Clinical narrative: Patient is a 86 y.o. male patient with history of CAD, HTN, DVT/PE, GI bleed, NIDDM2, prostate cancer who presented to Hospital with weakness, chills.   Acute respiratory failure with hypoxia With recent viral URI symptoms 2 weeks prior to admission, though had negative rapid antigen at home at that time, possibly symptoms from new COVID or potential secondary bacterial pneumonia CXR on admission with few increased markings in the right infrahilar region.  Findings could represent atelectasis or an early infiltrate  Requiring 2L nasal cannula on admission Procalcitonin, urine antigens negative- stopped empirin antibiotics  Continue dexamethasone, held remdesivir given unclear timing Weaned off oxygen   COVID-19 virus infection Date of onset of symptoms: unclear, had URI symptoms 2-3 weeks ago with improvement, then fatigue, weakness, chills on 10/26 Date of covid positive test: 10/26 Vaccination status: vaccinated without most recent booster Imaging: CXR as above Oxygen requirements on admission: 2L Current oxygen requirements: 2L Medical therapy: steroids, antibiotics as above, holding remdesivir given unclear timing of symptoms Consultants following: PT/OT Anticipated special isolation end date while in hospital: 11/5 Stable on room air Patient advised about precautions after discharge    Chronic Thrombocytopenia Has been low in past   CAD Prior CABG remotely and stent Continue home imdur, aspirin, Xarelto, statin   History of DVT/PE Continue home Xarelto   HTN On hydrochlorothiazide, losartan, imdur at home Resume home regimen   Chronic HFpEF Continue home hydrochlorothiazide  Patient to start Entresto soon on discharge    History of GI bleed In April 2023, found to have small bowel AVMs PPI BID continued   NIDDM2 On metformin at home SSI while admitted Poor control due to steroids    OSA CPAP
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Condition aggravated, Diabetes mellitus inadequate control, Fatigue, Gastrointestinal arteriovenous malformation, Gastrointestinal haemorrhage
Clinical narrative: Patient is a 86 y.o. male patient with history of CAD, HTN, DVT/PE, GI bleed, NIDDM2, prostate cancer who presented to Hospital with weakness, chills.   Acute respiratory failure with hypoxia With recent viral URI symptoms 2 weeks prior to admission, though had negative rapid antigen at home at that time, possibly symptoms from new COVID or potential secondary bacterial pneumonia CXR on admission with few increased markings in the right infrahilar region.  Findings could represent atelectasis or an early infiltrate  Requiring 2L nasal cannula on admission Procalcitonin, urine antigens negative- stopped empirin antibiotics  Continue dexamethasone, held remdesivir given unclear timing Weaned off oxygen   COVID-19 virus infection Date of onset of symptoms: unclear, had URI symptoms 2-3 weeks ago with improvement, then fatigue, weakness, chills on 10/26 Date of covid positive test: 10/26 Vaccination status: vaccinated without most recent booster Imaging: CXR as above Oxygen requirements on admission: 2L Current oxygen requirements: 2L Medical therapy: steroids, antibiotics as above, holding remdesivir given unclear timing of symptoms Consultants following: PT/OT Anticipated special isolation end date while in hospital: 11/5 Stable on room air Patient advised about precautions after discharge    Chronic Thrombocytopenia Has been low in past   CAD Prior CABG remotely and stent Continue home imdur, aspirin, Xarelto, statin   History of DVT/PE Continue home Xarelto   HTN On hydrochlorothiazide, losartan, imdur at home Resume home regimen   Chronic HFpEF Continue home hydrochlorothiazide  Patient to start Entresto soon on discharge    History of GI bleed In April 2023, found to have small bowel AVMs PPI BID continued   NIDDM2 On metformin at home SSI while admitted Poor control due to steroids    OSA CPAP
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoxia, Procalcitonin normal, Respiratory symptom, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: Patient is a 86 y.o. male patient with history of CAD, HTN, DVT/PE, GI bleed, NIDDM2, prostate cancer who presented to Hospital with weakness, chills.   Acute respiratory failure with hypoxia With recent viral URI symptoms 2 weeks prior to admission, though had negative rapid antigen at home at that time, possibly symptoms from new COVID or potential secondary bacterial pneumonia CXR on admission with few increased markings in the right infrahilar region.  Findings could represent atelectasis or an early infiltrate  Requiring 2L nasal cannula on admission Procalcitonin, urine antigens negative- stopped empirin antibiotics  Continue dexamethasone, held remdesivir given unclear timing Weaned off oxygen   COVID-19 virus infection Date of onset of symptoms: unclear, had URI symptoms 2-3 weeks ago with improvement, then fatigue, weakness, chills on 10/26 Date of covid positive test: 10/26 Vaccination status: vaccinated without most recent booster Imaging: CXR as above Oxygen requirements on admission: 2L Current oxygen requirements: 2L Medical therapy: steroids, antibiotics as above, holding remdesivir given unclear timing of symptoms Consultants following: PT/OT Anticipated special isolation end date while in hospital: 11/5 Stable on room air Patient advised about precautions after discharge    Chronic Thrombocytopenia Has been low in past   CAD Prior CABG remotely and stent Continue home imdur, aspirin, Xarelto, statin   History of DVT/PE Continue home Xarelto   HTN On hydrochlorothiazide, losartan, imdur at home Resume home regimen   Chronic HFpEF Continue home hydrochlorothiazide  Patient to start Entresto soon on discharge    History of GI bleed In April 2023, found to have small bowel AVMs PPI BID continued   NIDDM2 On metformin at home SSI while admitted Poor control due to steroids    OSA CPAP